Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
105.25
-3.42 (-3.15%)
At close: Jun 8, 2026, 4:00 PM EDT
105.00
-0.25 (-0.24%)
After-hours: Jun 8, 2026, 4:10 PM EDT
Palvella Therapeutics Market Cap
Palvella Therapeutics has a market cap or net worth of $1.51 billion as of June 8, 2026. Its market cap has increased by 493.67% in one year.
Market Cap
1.51B
Enterprise Value
1.27B
1-Year Change
493.67%
Ranking
Category
Stock Price
$105.25
Market Cap Chart
Since December 16, 2024, Palvella Therapeutics's market cap has increased from $143.97M to $1.51B, an increase of 948.55%. That is a compound annual growth rate of 395.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 1.56B | 25.81% |
| Dec 31, 2025 | 1.24B | 820.07% |
| Dec 31, 2024 | 134.66M | -6.47% |
| Dec 16, 2024 | 143.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tyra Biosciences | 1.59B |
| Ascentage Pharma Group International | 1.59B |
| Fortrea Holdings | 1.57B |
| Taysha Gene Therapies | 1.56B |
| Capricor Therapeutics | 1.51B |
| Sionna Therapeutics | 1.51B |
| Syndax Pharmaceuticals | 1.50B |
| AnaptysBio | 1.49B |